S&P Futures
3,825.00-14.00(-0.36%)Dow Futures
31,457.00-8.00(-0.03%)Nasdaq Futures
12,520.25-143.50(-1.13%)
CRSP Apr 2021 50.000 put
| Previous Close | 0.4000 |
| Open | 0.4000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 50.00 |
| Expire Date | 2021-04-16 |
| Day's Range | 0.2300 - 0.4000 |
| Contract Range | N/A |
| Volume | 2 |
| Open Interest | N/A |
- Insider Monkey
Cathie Wood’s Top 10 Stock Picks
In this article we discuss Cathie Wood’s top 10 stock picks. You can skip our detailed analysis of Cathie Wood’s investment strategy and go directly to Cathie Wood’s Top 5 Stock Picks. Ark Investment’s Cathie Wood has become one of the most popular hedge fund managers and investors, thanks to her successful bets on technology, […]
- Zacks
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $114.65, marking a -0.73% move from the previous day.
- Barrons.com
Vertex Stock Fell After a Setback on a New Drug. It’s an Opportunity for Investors.
Then, in mid-October, the biotech company canceled development of a once-promising drug after trial results disappointed. Despite the slide in the stock, little has actually changed for Vertex’s business. Vertex (ticker: VRTX) is a powerhouse in cystic fibrosis treatment, selling $6.2 billion worth of such drugs in 2020.
